Alcoholic hepatitis: Towards an era of personalised management
- PMID: 32718222
- PMCID: PMC7724541
- DOI: 10.1177/2050640620945886
Alcoholic hepatitis: Towards an era of personalised management
Abstract
Alcoholic hepatitis should be suspected in every patient with excessive chronic alcohol consumption and recent onset of jaundice. Diagnosis of alcoholic hepatitis is based on clinical and laboratory findings, and confirmed by a liver biopsy when available. Several scores are available to assess severity and prognosis of alcoholic hepatitis. The 1-month mortality of patients with severe alcoholic hepatitis, as defined by Maddrey's discriminant function, is 20-30%. Therefore, severe alcoholic hepatitis should be treated with a 28-day course of oral prednisolone after systematic screening for infection. In this review, we discuss diagnosis of alcoholic hepatitis, the different scores to assess severity of the disease, indications for corticosteroid therapy and alternative therapeutic options for non-responders to medical therapy.
Keywords: Alcoholic hepatitis; Lille score; disease severity; liver transplantation; prednisolone.
Conflict of interest statement
Figures

Comment in
-
Severe alcoholic hepatitis: Jumping from the frying pan into the fire.United European Gastroenterol J. 2021 May;9(4):517-518. doi: 10.1002/ueg2.12065. Epub 2021 Apr 22. United European Gastroenterol J. 2021. PMID: 33887118 Free PMC article. No abstract available.
References
-
- European Association for the Study of the Liver. EASL clinical practice guidelines: Management of alcohol-related liver disease. J Hepatol 2018; 69: 154–181. - PubMed
-
- Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 2015; 372: 1619–1628. - PubMed
-
- Mathurin P, Duchatelle V, Ramond MJ, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996; 110: 1847–1853. - PubMed
-
- Mathurin P, Mendenhall CL, Carithers RL, Jr, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002; 36: 480–487. - PubMed
-
- Degré D, Stauber RE, Englebert G, et al. Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32. J Hepatol 2020; 72: 636–642. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical